Calamos Advisors’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Calamos Advisors’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,000	Closed	-$259K	–	1314
2022 Q4	$259K	Hold	25,000	–	–	﹤0.01%	936
2022 Q3	$254K	Buy	+25,000	New	+$253K	﹤0.01%	1043

Calamos Advisors's THAC Position: Q1 2023 in Review

Calamos Advisors sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 25,000 shares — an estimated $259K sold.

Calamos Advisors first reported a position in THAC in Q3 2022 and held it in 2 quarters. The position peaked at $259K in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Calamos Advisors reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Calamos Advisors sold 25,000 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $259K.
Calamos Advisors first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q3 2022 and held it in 2 quarters.
Calamos Advisors's Thrive Acquisition Corporation Class A ordinary shares position peaked at $259K in Q4 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.